| Date Checked | 2026-02-19 22:14:44 |
|---|---|
| Graham Number | (PB)nan vs (PE)136.38 |
| Over / Under Value Percentage | 0.00% vs nan% |
| Dividend Yield | 0.35% |
| Dividend Date | 2026-01-02 |
| Symbol | MCK |
| AssetType | Common Stock |
| Name | McKesson Corporation |
| Description | McKesson Corporation (MCK) stands as a pivotal leader in the U.S. healthcare sector, excelling in the distribution of pharmaceuticals and medical supplies, as well as offering innovative healthcare management solutions. With a strong focus on leveraging advanced technology, McKesson enhances operational efficiencies for a wide array of healthcare stakeholders, including providers, payers, and pharmaceutical partners. The company’s commitment to innovation not only solidifies its competitive position but also drives improved patient outcomes and more effective healthcare delivery. As a vital player in the rapidly evolving healthcare landscape, McKesson is dedicated to promoting a more efficient, patient-centered approach to healthcare services. |
| CIK | 927653 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | MEDICAL DISTRIBUTION |
| Address | 6555 STATE HIGHWAY 161, IRVING, TX, UNITED STATES, 75039 |
| OfficialSite | https://www.mckesson.com |
| FiscalYearEnd | March |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 102818628000 |
| EBITDA | 6507000000 |
| PERatio | 25.84 |
| PEGRatio | 1.008 |
| BookValue | -14.02 |
| DividendPerShare | 2.95 |
| EPS | 31.99 |
| RevenuePerShareTTM | 3096.75 |
| ProfitMargin | 0.0104 |
| OperatingMarginTTM | 0.0137 |
| ReturnOnAssetsTTM | 0.0478 |
| ReturnOnEquityTTM | 0 |
| RevenueTTM | 387093987000 |
| GrossProfitTTM | 13324000000 |
| DilutedEPSTTM | 31.99 |
| QuarterlyEarningsGrowthYOY | 3.77 |
| QuarterlyRevenueGrowthYOY | 0.101 |
| AnalystTargetPrice | 942 |
| AnalystRatingStrongBuy | 3 |
| AnalystRatingBuy | 10 |
| AnalystRatingHold | 3 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | 25.84 |
| ForwardPE | 19.05 |
| PriceToSalesRatioTTM | 0.266 |
| PriceToBookRatio | 5.04 |
| EVToRevenue | 0.281 |
| EVToEBITDA | 17.91 |
| Beta | 0.409 |
| 52WeekHigh | 894.75 |
| 52WeekLow | 568.11 |
| 50DayMovingAverage | 830.7 |
| 200DayMovingAverage | 751.71 |
| SharesOutstanding | 123427000 |
| SharesFloat | 123258000 |
| PercentInsiders | 0.029 |
| PercentInstitutions | 90.915 |
| ExDividendDate | 2026-03-02 |
| dateChecked | 2026-02-19 22:14:44 |
| fresh | 1 |